Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-07-16 Warmuth Markus President & CEO Sale −9,500 $23.18 $220K 585,038
2026-06-01 Warmuth Markus President & CEO Sale 10b5-1 −4,998 $19.41 $97K 595,006
2026-06-01 Warmuth Markus President & CEO Sale 10b5-1 −468 $19.73 $9K 594,538
2026-05-01 Warmuth Markus President & CEO Sale 10b5-1 −5,467 $18.92 $103K 600,004
2026-04-14 Warmuth Markus President & CEO Sale −8,000 $17.64 $141K 605,471
2026-03-02 Warmuth Markus President & CEO Sale 10b5-1 −5,466 $17.92 $98K 613,471
2026-01-07 Warmuth Markus President & CEO Sale 10b5-1 −3,707 $23.24 $86K 620,696
2026-01-07 Warmuth Markus President & CEO Sale 10b5-1 −1,450 $23.88 $35K 619,246
2026-01-07 Warmuth Markus President & CEO Sale 10b5-1 −309 $24.57 $8K 618,937
2026-01-05 Warmuth Markus President & CEO Sale −10,135 $15.17 $154K 624,403
2026-01-02 Warmuth Markus President & CEO Grant or award +90,000 634,538
2026-01-02 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +406,000 406,000
2025-01-02 Warmuth Markus President & CEO Grant or award +128,000 544,538
2025-01-02 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +575,000 575,000
2024-01-02 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +346,000 346,000
2023-01-03 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +472,000 472,000
2022-03-01 Warmuth Markus President & CEO Grant or award · Stock Option (Right to Buy) +315,600 315,600
2021-06-23 Warmuth Markus See Remarks Grant or award · Stock Option (Right to Buy) +141,623 141,623
2021-04-12 Warmuth Markus See Remarks Grant or award · Stock Option (Right to Buy) +538,517 538,517

Page 1 of 1 · 19 trades